Grant share is based on the ratio of number of grants to total number of patents. The granted patent US12030914B2 outlines a polynucleotide that encodes a modified adeno-associated virus (AAV) capsid ...

Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology's annual meeting in Chicago, October 17-21, 2024. Avirmax will exhibit at booth #5357 to showcase the ...

After hours: October 14 at 5:27 PM EDT Loading Chart for ADVM ...

Avirmax Biopharma Is Unlocking Potential of Genetic Medicine, Preserving Vision for Millions of Patients With a mission of unlocking the great potential of AAV based ... and AAV2.7m8 in mice ...

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today ...